Alerts will be sent to your verified email
Verify Email
LINKPH
|
Link Pharma Chem
|
Parmax Pharma
|
Cian Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.59 % | -1068.03 % | -17.04 % |
|
5yr average Equity Multiplier
|
1.99 | 29.23 | 3.21 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 1.05 | 0.39 |
|
5yr Avg Net Profit Margin
|
-0.06 % | -11.29 % | -17.41 % |
|
Price to Book
|
1.07 | 0.0 | 0.4 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
82.44 Days | -92.25 Days | 55.28 Days |
|
Inventory Days
|
64.96 Days | 69.37 Days | 219.95 Days |
|
Days Receivable
|
72.97 Days | 20.01 Days | 224.43 Days |
|
Days Payable
|
84.21 Days | 296.94 Days | 542.88 Days |
|
5yr Average Interest Coverage Ratio
|
2.35 | -0.77 | -0.81 |
|
5yr Avg ROCE
|
5.35 % | -14.3 % | -0.26 % |
|
5yr Avg Operating Profit Margin
|
3.76 % | 2.43 % | 7.22 % |
|
5 yr average Debt to Equity
|
0.49 | 10.96 | 1.21 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
0.6 % | -9.05 % | -3.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.49 % | 30.8 % | 27.1 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 34.48 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -43.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Link Pharma Chem
|
Parmax Pharma
|
Cian Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|